NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 22 micro hospitals across 10 states, has announced its Q3 2024 financial results release schedule. The company will publish results after market close on November 7, 2024, followed by a conference call on November 8, 2024, at 10:30 am ET. Stakeholders can join via phone (1-877-407-9208 or 1-201-493-6784) or webcast, with a recording to be available on the company's website.
Nutex Health (NASDAQ: NUTX), un sistema sanitario guidato da medici con 22 micro ospedali in 10 stati, ha annunciato il programma di rilascio dei risultati finanziari per il terzo trimestre del 2024. L'azienda pubblicherà i risultati dopo la chiusura del mercato il 7 novembre 2024, seguito da una conferenza telefonica l'8 novembre 2024, alle 10:30 ET. Gli interessati possono partecipare tramite telefono (1-877-407-9208 o 1-201-493-6784) o in webcast, e una registrazione sarà disponibile sul sito web dell'azienda.
Nutex Health (NASDAQ: NUTX), un sistema de atención médica dirigido por médicos con 22 micro hospitales en 10 estados, ha anunciado su programación para la publicación de resultados financieros del tercer trimestre de 2024. La empresa publicará los resultados después del cierre del mercado el 7 de noviembre de 2024, seguido de una llamada de conferencia el 8 de noviembre de 2024, a las 10:30 am ET. Los interesados pueden unirse por teléfono (1-877-407-9208 o 1-201-493-6784) o mediante webcast, y se dispondrá de una grabación en el sitio web de la empresa.
Nutex Health (NASDAQ: NUTX)는 10개 주에 22개의 마이크로 병원을 운영하는 의사 주도의 의료 시스템으로, 2024년 3분기 재무 결과 발표 일정을 발표했습니다. 회사는 2024년 11월 7일 시장 마감 후 결과를 발표하며, 2024년 11월 8일 오전 10:30 ET에 컨퍼런스 콜이 진행됩니다. 이해 관계자는 전화 (1-877-407-9208 또는 1-201-493-6784) 또는 웹캐스트를 통해 참여할 수 있으며, 회사 웹사이트에서 녹음된 내용도 제공될 예정입니다.
Nutex Health (NASDAQ: NUTX), un système de santé dirigé par des médecins avec 22 micro-hôpitaux dans 10 États, a annoncé son calendrier de publication des résultats financiers du troisième trimestre de 2024. L'entreprise publiera les résultats après la fermeture du marché le 7 novembre 2024, suivie d'une conférence téléphonique le 8 novembre 2024 à 10h30 ET. Les parties prenantes peuvent rejoindre par téléphone (1-877-407-9208 ou 1-201-493-6784) ou par webcast, une enregistrement sera disponible sur le site web de l'entreprise.
Nutex Health (NASDAQ: NUTX), ein von Ärzten geführtes Gesundheitssystem mit 22 Mikrokrankenhäusern in 10 Bundesstaaten, hat seinen Zeitplan für die Veröffentlichung der finanziellen Ergebnisse des dritten Quartals 2024 bekannt gegeben. Das Unternehmen wird die Ergebnisse nach Börsenschluss am 7. November 2024 veröffentlichen, gefolgt von einer Telefonkonferenz am 8. November 2024, um 10:30 Uhr ET. Interessenvertreter können per Telefon (1-877-407-9208 oder 1-201-493-6784) oder über einen Webcast teilnehmen, und eine Aufzeichnung wird auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
Participant Listening: 1-877-407-9208 or 1-201-493-6784
Participant webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1691722&tp_key=bfd69ce352
To access the call, please dial in approximately five minutes before start time. Those who are unable to attend the live conference call may access the recording on the Company's website.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in 10 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). We provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "expects to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including final rules implemented under the No Surprises Act and related regulatory guidance, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Report on Form 10-Q for the period ended September 30, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-schedules-2024-third-quarter-financial-results-release-and-conference-call-302296281.html
SOURCE Nutex Health, Inc.
FAQ
When will Nutex Health (NUTX) release Q3 2024 earnings?
When is Nutex Health's (NUTX) Q3 2024 earnings call?
How many micro hospitals does Nutex Health (NUTX) operate?